Genertec secures deals worth more than $700 million at the CIIE
According to China General Technology (Group) Holding Co., Ltd, published on 11 November 2026, the ninth China International Import Expo and Hongqiao International Economic Forum ran from 5 to 10 November at the National Exhibition and Convention Centre in Shanghai. The group held a sequence of activities covering forum exchanges, supplier meetings and global procurement signings during the event, drawing international resources and fostering industrial collaboration through the exhibition platform.

As a centrally administered state-owned enterprise that has taken part in all nine editions of the expo, Genertec signed thirteen separate project agreements with thirteen overseas partners during the show, with a combined value exceeding 700 million US dollars. The agreements span high-end equipment research and manufacturing, pharmaceuticals and healthcare, overseas energy engineering and commodity trading. These arrangements align with the group’s core business lines and support efforts to reinforce and extend industrial supply chains.
The project portfolio covers distinct business streams. The group’s machine-tool subsidiary completed its first signing at the expo, marking the first CIIE contract for its machine-tool platform. Co-operation within its healthcare division expands access to innovative medical devices and advanced clinical supplies, improving patient access to new therapies within China. Overseas energy engineering work supports the Belt and Road Initiative, matching the group’s engineering capacity with demand in foreign markets. Purchases of sesame, groundnuts and liquorice stabilise upstream supply and underpin domestic commodity availability.
Teams from Genertec also arranged on-site meetings with exhibitors to review emerging technologies and finished goods and discuss practical co-operation, creating channels for co-ordination along industrial chains. The group will focus on its core operations and sustain international engagement to translate signed agreements into delivery, while building closer commercial links with overseas partners to integrate scientific and industrial innovation.
